Trial Profile
Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomised phase II clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Aspirin; Carbasalate calcium; Clopidogrel; Dipyridamole
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms APACHE-AF
- 21 Mar 2021 Status changed from recruiting to completed.
- 03 Dec 2018 Planned End Date changed from 1 Sep 2018 to 31 Jan 2021.
- 03 Dec 2018 Planned primary completion date changed from 1 Mar 2018 to 31 Jan 2021.